3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
FED
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
46
Neoplasms
32
Lung Neoplasms
24
Colorectal Neoplasms
22
Uterine Cervical Neoplasms
14
Prostatic Neoplasms
13
Motor Activity
11
Colonic Neoplasms
10
Anxiety Disorders
9
Rectal Neoplasms
8
Obesity
8
Carcinoma, Non-Small-Cell Lung
8
Pancreatic Neoplasms
7
Hematologic Neoplasms
7
Endometrial Neoplasms
7
Depression
7
Ovarian Neoplasms
6
Lymphoma
6
Breast Carcinoma In Situ
6
Vulvar Neoplasms
5
Urinary Bladder Neoplasms
5
Neoplasm Metastasis
5
Hematopoietic and Lymphatic System Neoplasm
5
Triple Negative Breast Neoplasms
4
Smoking Cessation
4
Pain
4
Melanoma
4
Leukemia, Myeloid, Acute
4
Hematopoietic and Lymphoid System Neoplasm
4
Head and Neck Neoplasms
4
Interventions
Standard of Care
2
erythromycin propionate-N-acetylcysteinate
1
Therapeutics
1
Surgical Procedures, Operative
1
Practice Guidelines as Topic
1
Palliative Care
1
Methods
1
Mass Screening
1
Genes, p53
1
Focus Groups
1
Dignity Therapy
1
Coping Skills
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Death
×
Methods
×
Clear all
NCT00106067
2015-04-07
A&SC
VA Office of Research and Development
Phase NA
Completed
559 enrolled